Initial Single-Site Surgical Experience with SMILE: A Comparison of Results to FDA SMILE and the Earliest and Latest Generation of LASIK

摘要

IntroductionThe primary objective was to show our initial surgical single-site experience with small incision lenticule extraction (SMILE) after the official enrollment in March 2017 following Food and Drug Administration (FDA) approval for simple myopia in late 2016 in the United States and, subsequently, compare our results to the earliest and most advanced generation of excimer platforms for laser-assisted in situ keratomileusis (LASIK) surgery.